Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.

Saved in:
Bibliographic Details
Title: Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.
Authors: Di Lullo G; Tumor Immunology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Marcatti M; Hematology and Bone Marrow Transplantation Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Heltai S; Tumor Immunology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Brunetto E; Tumor Immunology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Tresoldi C; Hematology and Bone Marrow Transplantation Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Bondanza A; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Leukenia Immunotherapy Group; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Bonini C; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Experimental Hematology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Ponzoni M; Pathology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Molecular Oncology; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Tonon G; Division of Molecular Oncology; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Functional Genomics of Cancer Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Ciceri F; Hematology and Bone Marrow Transplantation Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy., Bordignon C; MolMed SpA ; Milan, Italy ; Vita-Salute San Raffaele University ; Milan, Italy., Protti MP; Tumor Immunology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy.
Source: Oncoimmunology [Oncoimmunology] 2015 Feb 03; Vol. 4 (5), pp. e1005460. Date of Electronic Publication: 2015 Feb 03 (Print Publication: 2015).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26155400
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Di+Lullo+G%22">Di Lullo G</searchLink>; Tumor Immunology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Marcatti+M%22">Marcatti M</searchLink>; Hematology and Bone Marrow Transplantation Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Heltai+S%22">Heltai S</searchLink>; Tumor Immunology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Brunetto+E%22">Brunetto E</searchLink>; Tumor Immunology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Tresoldi+C%22">Tresoldi C</searchLink>; Hematology and Bone Marrow Transplantation Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bondanza+A%22">Bondanza A</searchLink>; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Leukenia Immunotherapy Group; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bonini+C%22">Bonini C</searchLink>; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Experimental Hematology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ponzoni+M%22">Ponzoni M</searchLink>; Pathology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Molecular Oncology; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Tonon+G%22">Tonon G</searchLink>; Division of Molecular Oncology; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Functional Genomics of Cancer Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ciceri+F%22">Ciceri F</searchLink>; Hematology and Bone Marrow Transplantation Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bordignon+C%22">Bordignon C</searchLink>; MolMed SpA ; Milan, Italy ; Vita-Salute San Raffaele University ; Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Protti+MP%22">Protti MP</searchLink>; Tumor Immunology Unit; IRCCS San Raffaele Scientific Institute ; Milan, Italy ; Division of Immunology, Transplantation and Infectious Diseases; IRCCS San Raffaele Scientific Institute ; Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2015 Feb 03; Vol. 4 (5), pp. e1005460. <i>Date of Electronic Publication: </i>2015 Feb 03 (<i>Print Publication: </i>2015).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26155400
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2015.1005460
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1005460
    Titles:
      – TitleFull: Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Di Lullo G
      – PersonEntity:
          Name:
            NameFull: Marcatti M
      – PersonEntity:
          Name:
            NameFull: Heltai S
      – PersonEntity:
          Name:
            NameFull: Brunetto E
      – PersonEntity:
          Name:
            NameFull: Tresoldi C
      – PersonEntity:
          Name:
            NameFull: Bondanza A
      – PersonEntity:
          Name:
            NameFull: Bonini C
      – PersonEntity:
          Name:
            NameFull: Ponzoni M
      – PersonEntity:
          Name:
            NameFull: Tonon G
      – PersonEntity:
          Name:
            NameFull: Ciceri F
      – PersonEntity:
          Name:
            NameFull: Bordignon C
      – PersonEntity:
          Name:
            NameFull: Protti MP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 02
              Text: 2015 Feb 03
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-print
              Value: 2162-4011
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1